(Q82605776)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Ilona Schonn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jana Hennesen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dorothee C. Dartsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21107697

3 September 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21107697

3 September 2024

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 January 2020

http://link.springer.com/content/pdf/10.1007/s10495-010-0564-y.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

http://link.springer.com/article/10.1007/s10495-010-0564-y/fulltext.html

3 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

http://link.springer.com/content/pdf/10.1007/s10495-010-0564-y

3 September 2024

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

3 September 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

359-369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

Contribution of DNA repair and cell cycle checkpoint arrest to the maintenance of genomic stability

17 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Chromatin structural elements and chromosomal translocations in leukemia

3 September 2024

3

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage

3 September 2024

4

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Etoposide: four decades of development of a topoisomerase II inhibitor

3 September 2024

5

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Relationship between lethal effects and topoisomerase II-mediated double-stranded DNA breaks produced by anthracyclines with different sequence specificity

3 September 2024

8

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

3 September 2024

10

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Detection of adriamycin-DNA adducts by accelerator mass spectrometry

3 September 2024

11

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Repair of idarubicin-induced DNA damage: a cause of resistance?

3 September 2024

14

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.

3 September 2024

16

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Impact of 1.8-GHz radiofrequency radiation (RFR) on DNA damage and repair induced by doxorubicin in human B-cell lymphoblastoid cells.

3 September 2024

17

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Partners and pathwaysrepairing a double-strand break.

3 September 2024

19

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Backup pathways of NHEJ in cells of higher eukaryotes: cell cycle dependence

3 September 2024

20

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

From DNA end chemistry to cell-cycle response: the importance of structure, even when it's broken.

3 September 2024

21

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Repair of DNA covalently linked to protein.

3 September 2024

22

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

A protease pathway for the repair of topoisomerase II-DNA covalent complexes

3 September 2024

23

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

3 September 2024

24

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.

3 September 2024

25

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Apoptosis and APC in colorectal tumorigenesis

3 September 2024

26

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

3 September 2024

27

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Pharmacokinetic study of i.v. infusions of adriamycin

3 September 2024

29

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans

3 September 2024

32

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Drug Metabolism and Disposition

3 September 2024

33

17

98

P Speth

1989

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Reduction of TSG101 protein has a negative impact on tumor cell growth

3 September 2024

34

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis

3 September 2024

35

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

The comet assay: topical issues.

3 September 2024

36

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

The comet assay: a method to measure DNA damage in individual cells

3 September 2024

37

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells

3 September 2024

38

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin

3 September 2024

40

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest

3 September 2024

41

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death

3 September 2024

42

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells

3 September 2024

43

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Uncoupling of p21 induction and MyoD activation results in the failure of irreversible cell cycle arrest in doxorubicin-treated myocytes

3 September 2024

44

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Residual gammaH2AX foci as an indication of lethal DNA lesions

3 September 2024

45

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells

3 September 2024

46

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Cell fate decision mediated by p53 pulses

3 September 2024

47

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Activation of the DNA-dependent protein kinase by drug-induced and radiation-induced DNA strand breaks

3 September 2024

49

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Numerical analysis of etoposide induced DNA breaks

3 September 2024

50

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Rad51-independent interchromosomal double-strand break repair by gene conversion requires Rad52 but not Rad55, Rad57, or Dmc1.

3 September 2024

51

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

UnTTrapping the ends: a new player in overcoming protein linked DNA damage

3 September 2024

52

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Modulation of human DNA topoisomerase IIalpha function by interaction with 14-3-3epsilon

3 September 2024

53

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

3 September 2024

54

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

Role of proteasomal degradation in the cell cycle-dependent regulation of DNA topoisomerase IIalpha expression.

3 September 2024

55

1 reference

https://api.crossref.org/works/10.1007/S10495-010-0564-Y

3 September 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21107697%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference